NCT02005198已完成不适用
Assessing the Minimal Important Difference (MID) of the Treatment Related Impact Measure-Adult Growth Hormone Deficiency (TRIM-AGHD)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 98
- 试验地点
- 1
- 主要终点
- Changes in PGI (Patient Global Impression Scale)
研究概览
简要总结
This study is conducted in the United States of America (USA). The aim of the study is to assess the minimal important difference (MID) of the TRIM-AGHD.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 23 Years 至 79 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Able to speak read and write English
- •GHD (Growth Hormone Deficiency) treatment naïve which is defined as not being on a prescription treatment for their GHD currently and for at least 6 months
- •Beginning a new prescription GHD treatment and expected to be on this treatment for GHD for a minimum of 6 months
- •GHD of either one of the following criteria: a) Adult onset: subjects who have GHD, either alone or associated with multiple hormone deficiencies (hypopituitarism), as a result of pituitary disease, hypothalamic disease, surgery, radiation therapy, or traumatic brain injury (TBI), b) Childhood Onset: Subjects who were growth hormone deficient during childhood as a result of congenital, genetic, acquired, or idiopathic causes
- •Confirmed diagnosis of growth hormone deficiency (if a subject satisfies any one of the three following criteria): a) For the insulin tolerance test (ITT) or glucagon test both performed within the last five years: the validated cut-off for GHD in adults is a peak GH response of below 3.0 ng/mL (3 microg/L), b) For growth hormone releasing hormone (GHRH) +Arginine test performed within the last five years: for those subjects with a body mass index (BMI) below 25 kg/m^2, a peak GH below 11 ng/mL (microg /L); for BMI 25-30 kg/m^2, a peak GH below 8 ng/mL (8 microg/L); for BMI above 30 kg/m^2, a peak GH below 4 ng/mL 341 (4 microg/L ), c) Three or more pituitary hormone deficiencies at screening
- •Informed consent obtained before any study-related activities. (Study-related activities are any procedure related to recording of data according to the protocol)
排除标准
- •Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
- •Patients who have been on a prescription medication for treatment of GHD in past 6 months
- •Patients with a total Beck Depression Inventory II (BDI-II) score greater than 25
- •Females who are pregnant, breast-feeding or intend to become pregnant or are not using adequate contraceptive methods (adequate contraceptive measures as required by local law or practice)
- •Acute severe illness associated with weight loss in the last 6 months (defined as a loss of more than 5.0% total body weight)
- •Active Cushings syndrome within the last 24 months
- •Subject with overt diabetes mellitus
- •Previous participation in this study
结局指标
主要结局
Changes in PGI (Patient Global Impression Scale)
时间窗: After the physician scheduled visits closest to week 8 and week 26 after initiation of treatment
Changes in CGI (Clinician Global Impression Scale)
时间窗: After the physician scheduled visits closest to week 8 and week 26 after initiation of treatment
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Development of a MID for the 1-minute Sit-to-stand TestCOPDNCT02708719Schön Klinik Berchtesgadener Land105
已完成
不适用
Determination of a Minimal Clinically Important Difference of the "Functional Reach Test" in the Elderly.AgingNCT05853406Pole Sante Grace de Dieu60
尚未招募
不适用
Minimal Clinically Significant Difference (MCID) of Multidimensional Dyspnea Profile (MDP) in COPD Patients Undergoing Respiratory RehabilitationCOPDNCT06012006Assistance Publique - Hôpitaux de Paris120
招募中
不适用
MCID and PASS for Acute Pain and Quality of Recovery After Orthopedic SurgeryPain ManagementNCT04811209University Health Network, Toronto300
已完成
1 期
Investigating the clinical application of four balance measurement tools in people with Parkinson's diseaseParkinson's diseaseParkinson's Disease.IRCT20140612018077N3Iran University of Medical Sciences100